High-field 3 T imaging of Alzheimer disease

G. Luccichenti, P. Péran, A. Cherubini, E. Giugni, T. Scarabino, G. E. Hagberg, U. Sabatini

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Alzheimer disease (AD) is a neurodegenerative disease with neuronal loss, leading to dementia and neurological impairment [1]. Metabolic alterations are the basis of histological changes, occurring several years before cognitive impairment. In mild cognitive impairment (MCI) functional disability is absent; conversely, in Alzheimer dementia, disease progression is faster and disability occurs.

Original languageEnglish
Title of host publicationHigh Field Brain MRI: Use in Clinical Practice
PublisherSpringer Berlin Heidelberg
Pages201-207
Number of pages7
ISBN (Print)3540317759, 9783540317753
DOIs
Publication statusPublished - 2006

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'High-field 3 T imaging of Alzheimer disease'. Together they form a unique fingerprint.

  • Cite this

    Luccichenti, G., Péran, P., Cherubini, A., Giugni, E., Scarabino, T., Hagberg, G. E., & Sabatini, U. (2006). High-field 3 T imaging of Alzheimer disease. In High Field Brain MRI: Use in Clinical Practice (pp. 201-207). Springer Berlin Heidelberg. https://doi.org/10.1007/3-540-31776-7_17